Success Metrics

Clinical Success Rate
100.0%

Based on 8 completed trials

Completion Rate
100%(8/8)
Active Trials
0(0%)
Results Posted
38%(3 trials)

Phase Distribution

Ph phase_1
5
63%
Ph phase_2
1
13%
Ph phase_3
2
25%

Phase Distribution

5

Early Stage

1

Mid Stage

2

Late Stage

Phase Distribution8 total trials
Phase 1Safety & dosage
5(62.5%)
Phase 2Efficacy & side effects
1(12.5%)
Phase 3Large-scale testing
2(25.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

8 of 8 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

8

all time

Status Distribution
Completed(8)

Detailed Status

Completed8

Development Timeline

Analytics

Development Status

Total Trials
8
Active
0
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 15 (62.5%)
Phase 21 (12.5%)
Phase 32 (25.0%)

Trials by Status

completed8100%

Recent Activity

0 active trials
Showing 5 of 8
completedphase_1

Pulmonary Disposition of TR-700 Following Once-Daily Oral 200 mg

NCT01271998
completedphase_1

Pharmacokinetic (PK) Study of Oral and IV TR-701 FA in Adolescent Patients

NCT01156077
completedphase_3

TR-701 FA vs. Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections.

NCT01170221
completedphase_2

A Phase 2 Safety and Exploratory Skin Lesion Measurement of TR-701 FA Study

NCT01519778
completedphase_3

TR-701 FA vs Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections

NCT01421511
View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials
NCT01271998Phase 1

Pulmonary Disposition of TR-700 Following Once-Daily Oral 200 mg

Completed
NCT01156077Phase 1

Pharmacokinetic (PK) Study of Oral and IV TR-701 FA in Adolescent Patients

Completed
NCT01170221Phase 3

TR-701 FA vs. Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections.

Completed
NCT01519778Phase 2

A Phase 2 Safety and Exploratory Skin Lesion Measurement of TR-701 FA Study

Completed
NCT01421511Phase 3

TR-701 FA vs Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections

Completed
NCT01623401Phase 1

A Phase 1, Open-Label, 10 Day Safety Study

Completed
NCT01431833Phase 1

A PK and Safety Study in Subjects With Hepatic Impairment

Completed
NCT01452828Phase 1

A Pharmacokinetics and Safety Study in Subjects With Renal Impairment

Completed

All 8 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
8